NCT07536412 2026-04-17
Decision Aid Efficacy in Low Risk Thyroid Cancer
University of Maryland, Baltimore
Phase NA Not yet recruiting
Clinical Trials
72 trialsNCT01709292 2026-04-16
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07529080 2026-04-14
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
University of Michigan Rogel Cancer Center
Phase NA Not yet recruiting
NCT07521670 2026-04-13
STRAP
National Cancer Centre, Singapore
Phase 2 Not yet recruiting
NCT03753919 2026-03-11
DUTHY
Grupo Espanol de Tumores Neuroendocrinos
Phase 2 Terminated
NCT07440290 2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3 Not yet recruiting
NCT06235814 2026-02-05
MAPS
University of California, Los Angeles
Phase NA Completed
NCT06440850 2026-02-02
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
City of Hope Medical Center
Phase 2 Recruiting
NCT07376837 2026-01-29
PTC-RFA
University Health Network, Toronto
Phase NA Not yet recruiting
NCT05014698 2026-01-28
IDENTHY-K
Nantes University Hospital
Phase NA Terminated
NCT07354698 2026-01-21
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 4 Not yet recruiting
NCT07302672 2025-12-24
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
China-Japan Friendship Hospital
Phase NA Recruiting
NCT06623578 2025-12-03
Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT05768178 2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3 Recruiting
NCT04759911 2025-11-13
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04544111 2025-10-07
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04462471 2025-09-08
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02973997 2025-08-29
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
Academic and Community Cancer Research United
Phase 2 Completed
NCT01723202 2025-08-24
Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT04197960 2025-08-05
Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma
Chinese PLA General Hospital
Phase NA Completed
NCT03469011 2025-06-27
A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
AHS Cancer Control Alberta
Phase 1 Terminated
NCT06959641 2025-06-11
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Northwestern University
Phase 2 Recruiting
NCT04129411 2025-05-20
Treatment of Papillary Thyroid Carcinoma With Radiofrequency Ablation
Mayo Clinic
Phase NA Completed
NCT05003856 2025-04-02
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule
M.D. Anderson Cancer Center
Phase NA Terminated
NCT05410821 2025-04-01
Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Phase 1 Completed
NCT06899347 2025-03-27
PRO-COMAND
University of Pisa
Phase NA Not yet recruiting
NCT06804863 2025-02-03
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
West China Hospital
Phase NA Not yet recruiting
NCT05132205 2025-01-30
Radiofrequency Ablation of Papillary Thyroid Microcarcinoma
Johns Hopkins University
Phase NA Completed
NCT06800482 2025-01-30
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
West China Hospital
Phase NA Recruiting
NCT06791005 2025-01-24
A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
Second Affiliated Hospital of Xi'an Jiaotong University
Phase 3 Recruiting
NCT05668962 2024-12-12
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Massachusetts General Hospital
Phase 2 Recruiting
NCT05263141 2024-12-03
Retro-Auricular Single-Site Endoscopic to Papillary Thyroid Carcinoma
Sun Yat-sen University
Phase NA Completed
NCT05760690 2024-12-03
Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola
Sun Yat-sen University
Phase NA Completed
NCT02393690 2024-07-26
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Academic and Community Cancer Research United
Phase 2 Completed
NCT06468696 2024-06-21
Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients
Second Affiliated Hospital of Xi'an Jiaotong University
Phase NA Recruiting
NCT01398085 2024-05-08
IoN
University College, London
Phase 2/3 Active not recruiting
NCT03470259 2024-04-16
TARGET
University Medical Center Groningen
Phase 1 Completed
NCT05507775 2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA Completed
NCT06325787 2024-03-25
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
Chinese PLA General Hospital
Phase NA Completed
NCT04354324 2024-03-15
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
Zhujiang Hospital
Phase NA Unknown
NCT06271044 2024-02-21
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
Helsinki University Central Hospital
Phase NA Active not recruiting
NCT00415233 2023-12-19
HiLo
University College, London
Phase 3 Unknown
NCT05545852 2023-10-18
A Clinical Study of Transaxillary Endoscopic and Open Thyroidectomy for PTC
Nanfang Hospital, Southern Medical University
Phase NA Unknown
NCT03506048 2022-11-10
Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
Emory University
Phase 2 Terminated
NCT00470496 2022-07-25
Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT02418390 2022-06-01
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma
Seoul National University Hospital
Phase NA Completed
NCT05247476 2022-02-18
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
Zhongshan Hospital Xiamen University
Phase 4 Unknown
NCT03630120 2021-07-14
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT02138214 2020-12-21
Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer
University of Wisconsin, Madison
Phase 2 Completed
NCT00668811 2020-08-05
IIT Sutent
Medstar Health Research Institute
Phase 2 Completed